These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 499642)
1. Tolmetin and G-6-PD erythrocyte deficiency: research in vitro. Passiu G; Piras MG; Perpignano G; Ibba G; Carcassi U J Int Med Res; 1979; 7(5):351-3. PubMed ID: 499642 [TBL] [Abstract][Full Text] [Related]
2. Safety of flurbiprofen in subjects with G-6-PD deficiency. In vivo and in vitro results. Passiu G; Mela Q; Perpignano G; Frigerio R; Cacace E Int J Clin Pharmacol Res; 1984; 4(2):137-9. PubMed ID: 6469439 [TBL] [Abstract][Full Text] [Related]
4. Peripheral red blood cell survival invariance during pefloxacin treatment in subjects with glucose-6-phosphate dehydrogenase deficiency. Perpignano G; Mela Q; Ruggiero V; Pitzus F Drugs Exp Clin Res; 1990; 16(12):635-8. PubMed ID: 2130006 [TBL] [Abstract][Full Text] [Related]
5. Oxidation of glutathione by methylene blue is equivalent in G-6-PD deficient and normal erythrocytes. Kelner MJ; Alexander NM Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):265-8. PubMed ID: 3715203 [No Abstract] [Full Text] [Related]
6. Alterations in normal and G-6-PD deficient human erythrocytes of various ages after exposure to metabolites of hemolytic drugs. Fraser IM; Tilton BE; Vesell ES Pharmacology; 1971; 5(3):173-87. PubMed ID: 5119006 [No Abstract] [Full Text] [Related]
7. Redox and energetic state of red blood cells in G6PD deficiency, heterozygous beta-thalassemia and the combination of both. Magnani M; Stocchi V; Canestrari F; Cucchiarini L; Stocchi O; Coppa GV; Felici L; Giorgi PL; Fornaini G Acta Haematol; 1986; 75(4):211-4. PubMed ID: 3096052 [TBL] [Abstract][Full Text] [Related]
8. beta-Thalassemia trait and hyperbilirubinemia in G-6-PD deficient newborn infants. Meloni T; Erre S; Gallisai D; Cutillo S Eur J Pediatr; 1980 Aug; 134(2):119-20. PubMed ID: 7439196 [TBL] [Abstract][Full Text] [Related]
9. The effect of methyl oleate hydroperoxide, a possible toxic ozone intermediate, on human normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes. Williams P; Calabrese EJ; Moore GS Ecotoxicol Environ Saf; 1983 Apr; 7(2):242-8. PubMed ID: 6851934 [TBL] [Abstract][Full Text] [Related]
10. Hematological parameters and red blood cell morphological abnormality of Glucose-6-Phosphate dehydrogenase deficiency co-inherited with thalassemia. Pengon J; Svasti S; Kamchonwongpaisan S; Vattanaviboon P Hematol Oncol Stem Cell Ther; 2018 Mar; 11(1):18-24. PubMed ID: 28641093 [TBL] [Abstract][Full Text] [Related]
11. Useful agents for the study of glutathione metabolism in erythroyctes. Organic hydroperoxides. Srivastava SK; Awasthi YC; Beutler E Biochem J; 1974 May; 139(2):289-95. PubMed ID: 4447610 [TBL] [Abstract][Full Text] [Related]
12. An examination of the role of vitamin E in glucose-6-phosphate dehydrogenase deficiency. Newman JG; Newman TB; Bowie LJ; Mendelsohn J Clin Biochem; 1979 Oct; 12(5):149-51. PubMed ID: 519843 [TBL] [Abstract][Full Text] [Related]
13. Erythrocyte reduced glutathione level in sickle cell anaemia and glucose-6-phosphate dehydrogenase deficient Saudi subjects. al-Ali AK Ann Clin Biochem; 1994 May; 31 ( Pt 3)():296-7. PubMed ID: 8067674 [No Abstract] [Full Text] [Related]
14. An evaluation of the dorset sheep as a predictive animal model for the response of G-6-PD deficient human erythrocytes to a proposed systemic toxic ozone intermediate, methyl oleate hydroperoxide. Calabrese EJ; Moore GS; Williams PS Vet Hum Toxicol; 1983 Aug; 25(4):241-6. PubMed ID: 6623888 [TBL] [Abstract][Full Text] [Related]
15. Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine enantiomers and two putative metabolites--I. Effect on reduced glutathione, methemoglobin content and release of hemoglobin. Agarwal S; Gupta UR; Gupta RC; Anand N; Agarwal SS Biochem Pharmacol; 1988 Dec; 37(24):4605-9. PubMed ID: 3202898 [TBL] [Abstract][Full Text] [Related]
16. An evaluation of the dorset sheep as a predictive animal model for the response of glucose-6-phosphate dehydrogenase-deficient human erythrocytes to a proposed systemic toxic ozone intermediate, methyl oleate ozonide. Calabrese EJ; Williams PS; Moore GS Ecotoxicol Environ Saf; 1983 Aug; 7(4):416-22. PubMed ID: 6617568 [TBL] [Abstract][Full Text] [Related]
17. Effects of some metabolites of hemolytic drugs on young and old, normal and G-6-PD-deficient human erythrocytes. Fraser IM; Tilton BE; Vesell ES Ann N Y Acad Sci; 1971 Jul; 179():644-53. PubMed ID: 5285395 [No Abstract] [Full Text] [Related]
18. Influence of double genetic polymorphism on response to sulfamethazine. Woolhouse NM; Atu-Taylor LC Clin Pharmacol Ther; 1982 Mar; 31(3):377-83. PubMed ID: 7060320 [TBL] [Abstract][Full Text] [Related]
19. Occupational lead exposure, G-6PD deficiency and beta-thalassemia trait. Cherchi P; Carta P; Anni MS; Giacomina C; Alessio L; Casula D Med Lav; 1987; 78(1):75-84. PubMed ID: 3614087 [No Abstract] [Full Text] [Related]
20. The haematological effects of glucose-6-phosphate dehydrogenase deficiency and thalassaemia trait: interaction between the two genes at the phenotype level. Piomelli S; Siniscalco M Br J Haematol; 1969 Jun; 16(6):537-49. PubMed ID: 5802491 [No Abstract] [Full Text] [Related] [Next] [New Search]